Role of bone marrow adipocytes in bone metastasis development and progression: a systematic review

Purpose Bone marrow adipocytes (BMAs) are the most plentiful cells in the bone marrow and function as an endocrine organ by producing fatty acids, cytokines, and adipokines. Consequently, BMAs can interact with tumor cells, influencing both tumor growth and the onset and progression of bone metastasis. This review aims to systematically evaluate the role of BMAs in the development and progression of bone metastasis. Methods A comprehensive search was conducted on PubMed, Web of Science, and Scopus electronic databases, following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement standards, to identify studies published from March 2013 to June 2023. Two independent reviewers assessed and screened the literature, extracted the data, and evaluated the quality of the studies. The body of evidence was evaluated and graded using the ROBINS-I tool for non-randomized studies of interventions and the Systematic Review Centre for Laboratory Animal Experimentation (SYRCLE) tool for in vivo studies. The results were synthesized using descriptive methods. Results The search yielded a total of 463 studies, of which 17 studies were included in the final analysis, including 15 preclinical studies and two non-randomized clinical studies. Analysis of preclinical studies revealed that BMAs play a significant role in bone metastasis, particularly in prostate cancer followed by breast and malignant melanoma cancers. BMAs primarily influence cancer cells by inducing a glycolytic phenotype and releasing or upregulating soluble factors, chemokines, cytokines, adipokines, tumor-derived fatty acid-binding protein (FABP), and members of the nuclear receptor superfamily, such as chemokine (C-C motif) ligand 7 (CCL7), C-X-C Motif Chemokine Ligand (CXCL)1, CXCL2, interleukin (IL)-1β, IL-6, FABP4, and peroxisome proliferator-activated receptor γ (PPARγ). These factors also contribute to adipocyte lipolysis and regulate a pro-inflammatory phenotype in BMAs. However, the number of clinical studies is limited, and definitive conclusions cannot be drawn. Conclusion The preclinical studies reviewed indicate that BMAs may play a crucial role in bone metastasis in prostate, breast, and malignant melanoma cancers. Nevertheless, further preclinical and clinical studies are needed to better understand the complex role and relationship between BMAs and cancer cells in the bone microenvironment. Targeting BMAs in combination with standard treatments holds promise as a potential therapeutic strategy for bone metastasis.

[1]  Y. Miyagi,et al.  Bone marrow adipocytes induce cancer‐associated fibroblasts and immune evasion, enhancing invasion and drug resistance , 2023, Cancer science.

[2]  Yinghao Cao,et al.  Role of Interleukin-1 family in bone metastasis of prostate cancer , 2022, Frontiers in Oncology.

[3]  M. Uder,et al.  Non-Invasive Characterization of Experimental Bone Metastasis in Obesity Using Multiparametric MRI and PET/CT , 2022, Cancers.

[4]  E. Vazquez,et al.  Bone Progenitors Pull the Strings on the Early Metabolic Rewiring Occurring in Prostate Cancer Cells , 2022, Cancers.

[5]  M. Uder,et al.  Systemic PPARγ Antagonism Reduces Metastatic Tumor Progression in Adipocyte‐Rich Bone in Excess Weight Male Rodents , 2021, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  Sokol V. Todi,et al.  Adipocyte-driven unfolded protein response is a shared transcriptomic signature of metastatic prostate carcinoma cells. , 2021, Biochimica et biophysica acta. Molecular cell research.

[7]  T. L. Andersen,et al.  Myeloma-bone marrow adipocyte axis in tumour survival and treatment response , 2021, British Journal of Cancer.

[8]  F. N. Leeuwen,et al.  Amino Acid Depletion Therapies: Starving Cancer Cells to Death , 2021, Trends in Endocrinology & Metabolism.

[9]  P. Valet,et al.  The Chemokine Receptor CCR3 Is Potentially Involved in the Homing of Prostate Cancer Cells to Bone: Implication of Bone-Marrow Adipocytes , 2021, International journal of molecular sciences.

[10]  P. G. Frank,et al.  Low Levels of Omega-3 Long-Chain Polyunsaturated Fatty Acids Are Associated with Bone Metastasis Formation in Premenopausal Women with Breast Cancer: A Retrospective Study , 2020, Nutrients.

[11]  T. Robson,et al.  Obesity and Cancer Metastasis: Molecular and Translational Perspectives , 2020, Cancers.

[12]  J. Pettitt,et al.  Myeloma-Modified Adipocytes Exhibit Metabolic Dysfunction and a Senescence-Associated Secretory Phenotype , 2020, Cancer Research.

[13]  Xijie Yu,et al.  Bone Marrow Adipocytes, Adipocytokines, and Breast Cancer Cells: Novel Implications in Bone Metastasis of Breast Cancer , 2020, Frontiers in Oncology.

[14]  Xia Li,et al.  Caprylic acid (C8:0) promotes bone metastasis of prostate cancer by dysregulated adipo‐osteogenic balance in bone marrow , 2020, Cancer science.

[15]  Mengjia Tang,et al.  Bone marrow adipocytes enhance osteolytic bone destruction by activating 1q21.3(S100A7/8/9-IL6R)-TLR4 pathway in lung cancer , 2020, Journal of Cancer Research and Clinical Oncology.

[16]  P. Brodt,et al.  The chemokine CCL7 regulates invadopodia maturation and MMP-9 mediated collagen degradation in liver-metastatic carcinoma cells. , 2020, Cancer letters.

[17]  P. Maroni.  Leptin, Adiponectin, and Sam68 in Bone Metastasis from Breast Cancer , 2020, International journal of molecular sciences.

[18]  A. Xu,et al.  The role of adipose tissue senescence in obesity- and ageing-related metabolic disorders. , 2020, Clinical science.

[19]  Kai-Ping Chang,et al.  Association of subcutaneous and visceral adipose tissue with overall survival in Taiwanese patients with bone metastases – results from a retrospective analysis of consecutively collected data , 2020, PloS one.

[20]  E. Heath,et al.  Prostate Tumor Cell–Derived IL1β Induces an Inflammatory Phenotype in Bone Marrow Adipocytes and Reduces Sensitivity to Docetaxel via Lipolysis-Dependent Mechanisms , 2019, Molecular Cancer Research.

[21]  P. L. Bergsagel,et al.  Reprogrammed marrow adipocytes contribute to myeloma-induced bone disease , 2019, Science Translational Medicine.

[22]  Prahlad T. Ram,et al.  FABP4 as a key determinant of metastatic potential of ovarian cancer , 2018, Nature Communications.

[23]  Xijie Yu,et al.  Bone Marrow Adipocyte: An Intimate Partner With Tumor Cells in Bone Metastasis , 2018, Front. Endocrinol..

[24]  P. Brodt,et al.  Collagen IV-conveyed signals can regulate chemokine production and promote liver metastasis , 2018, Oncogene.

[25]  G. Lyman,et al.  Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States , 2018, BMC Cancer.

[26]  H. Takayanagi,et al.  Osteoimmunology: The Conceptual Framework Unifying the Immune and Skeletal Systems. , 2017, Physiological reviews.

[27]  Y. Hung,et al.  Circulating Soluble IL-6 Receptor Concentration and Visceral Adipocyte Size Are Related to Insulin Resistance in Taiwanese Adults with Morbid Obesity. , 2017, Metabolic syndrome and related disorders.

[28]  D. Edwards,et al.  Leukemic blasts program bone marrow adipocytes to generate a protumoral microenvironment. , 2017, Blood.

[29]  R. Baron,et al.  Parathyroid Hormone Directs Bone Marrow Mesenchymal Cell Fate. , 2017, Cell metabolism.

[30]  C. Qian,et al.  Adipogenic niches for melanoma cell colonization and growth in bone marrow. , 2017, Laboratory investigation; a journal of technical methods and pathology.

[31]  T. Trotter,et al.  Adipocyte-Lineage Cells Support Growth and Dissemination of Multiple Myeloma in Bone. , 2016, The American journal of pathology.

[32]  A. Fatatis,et al.  COOPERATION AMONG HETEROGENEOUS PROSTATE CANCER CELLS IN THE BONE METASTATIC NICHE , 2016, Oncogene.

[33]  M. Hernán,et al.  ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions , 2016, British Medical Journal.

[34]  M. Hüttemann,et al.  Bone marrow adipocytes promote the Warburg phenotype in metastatic prostate tumors via HIF-1α activation , 2016, Oncotarget.

[35]  A. Harris,et al.  Antiangiogenic and tumour inhibitory effects of downregulating tumour endothelial FABP4 , 2016, Oncogene.

[36]  P. Clézardin,et al.  The role of osteoclasts in breast cancer bone metastasis , 2016, Journal of bone oncology.

[37]  G. Schett,et al.  High fat diet increases melanoma cell growth in the bone marrow by inducing osteopontin and interleukin 6 , 2016, Oncotarget.

[38]  R. Faccio,et al.  Stromal-Initiated Changes in the Bone Promote Metastatic Niche Development. , 2016, Cell reports.

[39]  W. Maloney,et al.  Breast Cancer Cell Colonization of the Human Bone Marrow Adipose Tissue Niche1 , 2015, Neoplasia.

[40]  E. Fliers,et al.  Short‐Term Effect of Estrogen on Human Bone Marrow Fat , 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[41]  R. Orlowski,et al.  Mature adipocytes in bone marrow protect myeloma cells against chemotherapy through autophagy activation , 2015, Oncotarget.

[42]  I. Podgorski,et al.  Marrow adipocyte-derived CXCL1 and CXCL2 contribute to osteolysis in metastatic prostate cancer , 2015, Clinical & Experimental Metastasis.

[43]  A. Caplan,et al.  Identification of a Subpopulation of Marrow MSC-Derived Medullary Adipocytes That Express Osteoclast-Regulating Molecules: Marrow Adipocytes Express Osteoclast Mediators , 2014, PloS one.

[44]  F. Buttgereit,et al.  Targeting IL-6 and RANKL signaling inhibits prostate cancer growth in bone , 2014, Clinical & Experimental Metastasis.

[45]  O. MacDougald,et al.  Bone marrow adipose tissue is an endocrine organ that contributes to increased circulating adiponectin during caloric restriction. , 2014, Cell metabolism.

[46]  G. Liapakis,et al.  Corticotrophin-Releasing Factor (CRF) and the Urocortins Are Potent Regulators of the Inflammatory Phenotype of Human and Mouse White Adipocytes and the Differentiation of Mouse 3T3L1 Pre-Adipocytes , 2014, PloS one.

[47]  K. Ikeda,et al.  Age-related Marrow Adipogenesis Is Linked to Increased Expression of RANKL* , 2014, The Journal of Biological Chemistry.

[48]  M. Rovers,et al.  SYRCLE’s risk of bias tool for animal studies , 2014, BMC Medical Research Methodology.

[49]  L. Yao,et al.  Roles of the Chemokine System in Development of Obesity, Insulin Resistance, and Cardiovascular Disease , 2014, Journal of immunology research.

[50]  J. Shieh,et al.  Targeting Aerobic Glycolysis and HIF-1α Expression Enhance Imiquimod-induced Apoptosis in Cancer Cells , 2014, Oncotarget.

[51]  Young‐Hee Kang,et al.  Blockade of visfatin induction by oleanolic acid via disturbing IL-6-TRAF6-NF-κB signaling of adipocytes , 2014, Experimental biology and medicine.

[52]  Leah M. Cook,et al.  Integrating new discoveries into the “vicious cycle” paradigm of prostate to bone metastases , 2014, Cancer and Metastasis Reviews.

[53]  Daniel P Feldmann,et al.  Bone marrow adipocytes promote tumor growth in bone via FABP4-dependent mechanisms , 2013, Oncotarget.

[54]  P. Hojman,et al.  The role of intratumoral and systemic IL-6 in breast cancer , 2013, Breast Cancer Research and Treatment.

[55]  T. Lange,et al.  p65-Dependent production of interleukin-1β by osteolytic prostate cancer cells causes an induction of chemokine expression in osteoblasts. , 2012, Cancer letters.

[56]  G. Mills,et al.  Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth , 2011, Nature Medicine.

[57]  Yuan Yuan Wang,et al.  Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. , 2011, Cancer research.

[58]  J. Pouysségur,et al.  Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer , 2009, Journal of cellular and molecular medicine.

[59]  E. Distel,et al.  The infrapatellar fat pad in knee osteoarthritis: an important source of interleukin-6 and its soluble receptor. , 2009, Arthritis and rheumatism.

[60]  D. Moher,et al.  Reprint--preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2009, Physical therapy.

[61]  R. Moreno-Sánchez,et al.  HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms. , 2009, Mini reviews in medicinal chemistry.

[62]  D. Moher,et al.  Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, PloS one.

[63]  Julien Verrax,et al.  Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. , 2008, The Journal of clinical investigation.

[64]  T. Asano,et al.  DNA microarray analyses of genes expressed differentially in 3T3-L1 adipocytes co-cultured with murine macrophage cell line RAW264.7 in the presence of the toll-like receptor 4 ligand bacterial endotoxin , 2008, International Journal of Obesity.

[65]  Frank Brombacher,et al.  Macrophage-specific PPARγ controls alternative activation and improves insulin resistance , 2007, Nature.

[66]  L. Suva,et al.  Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone. , 2007, Endocrinology.

[67]  Alberto Mantovani,et al.  Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. , 2006, European journal of cancer.

[68]  G. Semenza,et al.  HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. , 2006, Cell metabolism.

[69]  N. Denko,et al.  HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. , 2006, Cell metabolism.

[70]  Ketan Sheth1,et al.  Management of Hepatic Metastases from Colorectal Cancer , 2005, Clinics in colon and rectal surgery.

[71]  H. Bruunsgaard,et al.  Inflammatory mediators in the elderly , 2004, Experimental Gerontology.

[72]  Kozo Nakamura,et al.  PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. , 2004, The Journal of clinical investigation.

[73]  Huasheng Lu,et al.  Hypoxia-inducible Factor 1 Activation by Aerobic Glycolysis Implicates the Warburg Effect in Carcinogenesis* , 2002, The Journal of Biological Chemistry.

[74]  S. Paget.  The distribution of secondary growths in cancer of the breast. 1889. , 1989, Cancer metastasis reviews.

[75]  M. Lanotte,et al.  Production of monocyte/macrophage colony‐stimulating factor by preadipocyte cell lines derived from murine marrow stroma , 1982, Journal of cellular physiology.

[76]  Neoplastic Diseases: A Treatise on Tumours , 1928, The Indian Medical Gazette.

[77]  M. Konopleva,et al.  Leukemia Stem Cells Microenvironment. , 2017, Advances in experimental medicine and biology.

[78]  H. Iwase,et al.  [Breast cancer]. , 2006, Nihon rinsho. Japanese journal of clinical medicine.

[79]  I. Macdonald,et al.  Metastasis: Dissemination and growth of cancer cells in metastatic sites , 2002, Nature Reviews Cancer.

[80]  R. Rubens,et al.  Bone Metastases , 1991, Springer London.